ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2015

Can an oral antidiabetic (rosiglitazone) be of benefit in leukemia treatment?

Sevki Cetinkalp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.